Charlotte's Web Provides Update on Diverging Hemp Policies: Federal Momentum Builds as California Restricts Therapeutic Hemp Product Access
Charlotte's Web Announces Board Transition as Co-Founder Jared Stanley Deepens Focus on DeFloria
Charlotte's Web Appoints Jeff Raborn to Board of Directors
Charlotte's Web Announces Closing of Transaction with British American Tobacco, Including US$10 Million Investment
Charlotte's Web Reports Shareholder Meeting Voting Results
Charlotte's Web First Quarter 2026 Financial Results
CURED Nutrition Joins One Hemp, Strengthening Industry Alignment Ahead of Key Federal Legislative Deadline
Charlotte's Web Holdings, Inc. (CWEB:CA) Q4 2025 Earnings Call Transcript
Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results
Charlotte's Web Announces Transaction with BAT: Debenture Conversion and US$10M Equity Investment to Strengthen Balance Sheet
Charlotte's Web 2025 Fourth Quarter and Year-End Earnings Call and Webcast Notice
Charlotte's Web Welcomes New CMS Guidance, Advancing Access to Eligible Full‑Spectrum Hemp Products
Charlotte’s Web (OTCMKTS:CWBHF) Stock Price Up 3.4% – Time to Buy?
Charlotte's Web Commends Representative Griffith for Leadership Introducing Hemp Enforcement, Modernization, and Protection (HEMP) Act
Presidential Executive Order Validates DeFloria's Strategy in Pharmaceutical Cannabinoid Drug Development
Charlotte's Web Serves as a Premier CBD Partner for Landmark Medicare and Medicaid Pilot Program
Charlotte's Web Reports Q3 2025 Results
Charlotte's Web Appoints M. Borgia Walker to Board of Directors
Charlotte's Web™ Expands its Brightside Line with Launch of Knockout Hemp THC Sleep Gummies
Charlotte's Web™ Expands Sleep Category with Launch of Quiet Sleep Mushroom Gummies
Charlotte's Web Announces Plans to Establish a Scientific Advisory Board
Charlotte's Web Holdings, Inc. (CWBHF) Q2 2025 Earnings Conference Call Transcript
Charlotte's Web Reports Year-Over-Year Growth For Q2 2025
Charlotte's Web 2025 Second Quarter Earnings Call and Webcast Notice
Charlotte's Web Reports Shareholder Meeting Voting Results
Charlotte's Web Reports Year-Over-Year Growth For Q1 2025
Charlotte's Web Holdings Inc. (CWBHF) Q4 2024 Earnings Call Transcript
Charlotte's Web Reports 2024 Fourth Quarter and Year-End Financial Results
Charlotte's Web 2024 Fourth Quarter Earnings Call and Webcast Notice
Charlotte's Web Announces DeFloria to enter Phase 2 FDA Clinical Trial for Autism Spectrum Disorder Treatment
DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD)
Charlotte's Web Provides Update on DeFloria's Phase 1 Results Targeting Autism Spectrum Disorder
DeFloria Announces Positive Results from Phase 1 Trial of AJA001 Being Developed for the Treatment of Autism Spectrum Disorder (ASD)
Charlotte's Web Reports 2024 Third quarter Financial Results
Tilray Brands Launches Charlotte's Web™ CBD Gummies in Canada
ONE HEMP Hails Long Overdue Congressional Action Toward the Regulation of CBD as a Dietary Supplement
Charlotte's Web Responds to New Regulatory Developments in California Affecting the Sale of Hemp CBD Products
Charlotte's Web Reports 2024 Second Quarter Financial Results
Charlotte's Web 2024 Second Quarter Earnings Call and Webcast Notice
Charlotte's Web Debuts at Walmart with New CBD Topical Collection
Charlotte's Web Appoints Erika Lind as Chief Financial Officer
Charlotte's Web Announces Shareholder Meeting Voting Results
Farm Bill 2024: 3 Stocks That Would Get Smoked if Hemp Ban Passes
Charlotte's Web Holdings, Inc. (CWBHF) Q1 2024 Earnings Call Transcript
Charlotte's Web Reports 2024 First Quarter Financial Results
Charlotte's Web to Host Virtual Annual General & Special Meeting of Shareholders on June 13, 2024
Charlotte's Web 2024 First Quarter Earnings Call and Webcast Notice
3 Marijuana Stocks To Watch To Add To Your List This Week
Why Marijuana and CBD Stocks Were Buzzing Today
Charlotte's Web Holdings, Inc. (CWBHF) Q4 2023 Earnings Call Transcript